Sancuso

Active substance: granisetron

granisetron

Centralised EU authorisationActive

Marketing holder: Grünenthal GmbH

Verified 2026-10-09 · EMA

Composition

Analogues by country

Products with the same active substance registered in other countries.

Country	Products
US 14	Granisetron INJECTION, SOLUTION · GRANISETRON HYDROCHLORIDE 1 mg/mL 63323-318 Fresenius Kabi USA, LLC Granisetron Hydrochloride TABLET, FILM COATED · GRANISETRON HYDROCHLORIDE 1 mg/1 69452-350 Bionpharma Inc. Granisetron Hydrochloride TABLET · GRANISETRON HYDROCHLORIDE 1 mg/1 51991-735 Breckenridge Pharmaceutical, Inc. Granisetron Hydrochloride INJECTION, SOLUTION · GRANISETRON HYDROCHLORIDE .1 mg/mL 67457-861 Mylan Institutional LLC Granisetron Hydrochloride INJECTION, SOLUTION · GRANISETRON HYDROCHLORIDE 1 mg/mL 55150-175 Eugia US LLC All products in this country (14)

Country

Products

US 14

Granisetron
INJECTION, SOLUTION · GRANISETRON HYDROCHLORIDE 1 mg/mL
63323-318
Fresenius Kabi USA, LLC
Granisetron Hydrochloride
TABLET, FILM COATED · GRANISETRON HYDROCHLORIDE 1 mg/1
69452-350
Bionpharma Inc.
Granisetron Hydrochloride
TABLET · GRANISETRON HYDROCHLORIDE 1 mg/1
51991-735
Breckenridge Pharmaceutical, Inc.
Granisetron Hydrochloride
INJECTION, SOLUTION · GRANISETRON HYDROCHLORIDE .1 mg/mL
67457-861
Mylan Institutional LLC
Granisetron Hydrochloride
INJECTION, SOLUTION · GRANISETRON HYDROCHLORIDE 1 mg/mL
55150-175
Eugia US LLC

Import and control

United Statesprescription only
Source: openFDA NDC · record 01a1208c-8f5f-7bc9-8d89-9b61f515d2bc,01a1208c-af40-7ef4-a55f-9099fe3d6323,01a1208d-3b02-76f9-bf35-d87cee8885ef,01a1208d-70ec-7d51-95d9-e0b6b8790b11,01a1208d-7bce-7ddc-960a-2a0b3b685157;count=14 · valid from 2026-10-09 · verified 2026-10-09